Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 19,500 | |||
5 mg | 在庫あり | ¥ 45,000 | |||
10 mg | 在庫あり | ¥ 68,000 | |||
25 mg | 在庫あり | ¥ 114,000 | |||
50 mg | 在庫あり | ¥ 166,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 75,000 |
説明 | Anemarsaponin B has anti-inflammatory effect in LPS-treated RAW 264.7macrophages, the effect is associated with the inhibition of NF-κB transcriptional activity, possibly via the p38 MAP kinase pathway. Anemarsaponin B can inhibit PAF-induced rabbit platelet aggregation in vitro. |
植物由来 |
分子量 | 903.06 |
分子式 | C45H74O18 |
CAS No. | 139051-27-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (30.45 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
anemarsaponin B 139051-27-7 Immunology/Inflammation MAPK Neuroscience NF-Κb p38 MAPK NF-κB MEK COX NO Synthase Nuclear factor-kappaB MAP2K Mitogen-activated protein kinase kinase MAPKK Nuclear factor-κB NOS Cyclooxygenase Inhibitor Nitric oxide synthases inhibit inhibitor